The BMPR2-signalling pathway plays a well-recognised protective role against the development of PAH, and the genetic deficiency of BMPR2 is the most common cause of hereditary PAH [1], moreover, the expression of BMPR2 is reduced in the pulmonary vasculature of non-hereditary PAH patients [137]. This evidence concerns the gene BMPR2 and pulmonary arterial hypertension.